Treatment Use of Domperidone for Gastroparesis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02227927|
Expanded Access Status : Available
First Posted : August 28, 2014
Last Update Posted : November 21, 2017
Domperidone is a drug that may be of benefit to individuals with gastroesophageal reflux disease (GERD), with upper GI symptoms, gastroparesis, and chronic constipation.
This is a long-term treatment program for prescription of this drug to all patients who, in the investigators' judgement, could benefit from its use.
|Condition or disease||Intervention/treatment|
|Gastroesophageal Reflux Disease GERD Gastroparesis||Drug: Domperidone|
|Study Type :||Expanded Access|
|Official Title:||Treatment Use of Domperidone for Gastroparesis|
- Drug: Domperidone
10-30mg oral dose, four times daily.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02227927
|Contact: Jeannie Bongornofirstname.lastname@example.org|
|United States, Ohio|
|Cleveland, Ohio, United States, 44195|
|Contact: Scott Gabbard, MD 216-444-6523 GABBARS@ccf.org|